ReviewInternational immunopharmacology2023

Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial.

Mohsen Gholinataj Jelodar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.